DUBLIN--(BUSINESS WIRE)--The "Global Virus Filtration Market Report and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
According to the report, the global virus filtration market attained a value of USD 4054 million in 2021. Aided by the increasing prevalence of chronic diseases and high demand for biopharmaceutical drugs, the market is projected to further grow at a CAGR of 11.6% between 2022 and 2027 to reach USD 7769 million by 2027.
Virus filtration is a crucial component in the production of biological therapeutics. Virus filters offer viral retention for a variety of viruses through a large size-exclusion mechanism. Virus filtration is deemed an effective and a strong virus clearance technology. It is a generic unit operation in the manufacturing of biologicals and utilises a membrane barrier to preserve the particles of the virus. It is a size-based removal method that uses a specifically designed polymeric membrane to retain virus particles on the surface and within the pores of the membrane.
Further, biological development, like biopharmaceutical drugs, needs extreme precision and even a minor deviation in its protein structure is likely to result in alterations in medicine's quality, effectiveness, and safety. Consequently, the use of filtration products like chromatographic reagents, and kits are essential to prevent the adaptability in protein structure or denaturation of proteins, which is likely to negatively influence the demand for these products.
The global virus filtration market is expected to witness growth over the forecast period due to an upsurge in the prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, which is likely to bolster the demand for biopharmaceutical drugs. The increase in research and development expenditure coupled with the rising government support for the biotechnology and pharmaceutical industry is anticipated to fuel the market growth of virus filtration across the globe.
Also, the surging adoption of innovative healthcare technology solutions along with the increasing demand and application of single-use technologies and therapeutic biologics is anticipated to drive the virus filtration market growth across the globe. Geographically, North America is holding a significant growth in the market for virus filtration because of the presence of the well-established biotechnology and biopharmaceutical industry in the region.
Meanwhile, the Asia Pacific region is expected to register considerable growth in the market over the upcoming years on account of the extreme prevalence of chronic infection along with the growing population and improving healthcare facilities and infrastructure across the region.
Market Segmentation
The market can be divided on the basis of products, applications, end-uses, and regions.
Market Breakup by Product
- Kits, Reagents, and Consumables
- Filtration Systems
- Services
Market Segmentation by Application
- Biological
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Others
- Medical Devices
- Water Purification
- Air Purification
Market Breakup by End-Use
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
Market Breakup by Region
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East and Africa
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global virus filtration market.
Some of the major key players explored in the report are as follows:
- Asahi Kasei Corporation
- Charles River Laboratories International Inc.
- Danaher Corporation
- General Electric Company
- Sartorius AG
- Lonza Group Ltd
- Merck KgaA
- Pendo TECH
For more information about this report visit https://www.researchandmarkets.com/r/14iflu
